DigiPwn
Ebonwumon ACE (Alternate Art) (Animal Colosseum #EX5-041 R)

Ebonwumon ACE (Alternate Art) #EX5-041 R

Animal Colosseum · Mega · Digimon · Rare · 12000 DP · Foil only

Market prices

$2.23 market 0.0% 7d · updated Sep 11

PrintingLowMarketMedian
Foil$1.88$2.23$2.16

Price history

+$0.36 (+19.3%) over 33 days · High $2.31 · Low $1.87

Ebonwumon ACE (Alternate Art) market price, Feb 22 to Sep 13$2.31$2.09$1.87Feb 22Apr 24Sep 13
Daily prices (33 days)
DayMarketLowMedian
2026-09-13$2.23$1.88$2.16
2026-09-10$2.23$1.88$2.22
2026-09-07$2.23$1.88$2.22
2026-09-04$2.31$1.88$2.19
2026-06-17$2.14$1.90-
2026-06-10$2.16$1.90-
2026-06-06$2.14$1.90-
2026-06-02$2.11$1.90-
2026-05-29$2.10$1.82-
2026-05-25$2.10$1.82-
2026-05-22$2.10$1.82-
2026-05-18$2.10$1.83-
2026-05-14$2.10$1.71-
2026-05-10$2.10$1.71-
2026-05-02$2.10$1.82-
2026-04-28$2.09$1.82-
2026-04-24$2.09$1.82-
2026-04-20$2.09$1.82-
2026-04-16$2.09$1.83-
2026-04-12$2.04$1.83-
2026-04-08$2.04$1.83-
2026-04-05$2.04$1.71-
2026-04-01$1.95$1.83-
2026-03-28$1.95$1.83-
2026-03-25$1.95$1.82-
2026-03-21$1.95$1.71-
2026-03-17$1.95$1.83-
2026-03-13$1.95$1.71-
2026-03-08$1.89$1.71-
2026-03-05$1.89$1.71-
2026-03-02$1.87$1.49-
2026-02-25$1.87$1.49-
2026-02-22$1.87$1.49-

Details

Card type
Digimon
Colour
Green, Purple
Form
Mega
Level
6
Play cost
7
DP
12000
Attribute
Vaccine
Type
Holy Beast, Four Sovereigns
Digivolve
Lv.5 Green for 4, Lv.5 Purple for 4
Effect
[[Digivolve] Lv.5 w/[Deva] trait: Cost 3] [Hand] [Counter] [Blast Digivolve] (One of your Digimon may digivolve into this card without paying the cost.) [On Play] [When Digivolving] For each of your Digimon with the [Deva] or [Four Sovereigns] trait, suspend 1 of your opponent's Digimon. Then, during your opponent's next unsuspend phase, all of their Digimon can't unsuspend. [On Deletion] Delete 1 of your opponent's suspended Digimon. Overflow "-4" (When this card would move from the battle area or under a card to another area, lose 4 memory.)
Set
Animal Colosseum, released 2024-01-19
Card ID
695648

Comments

Sign in to join the conversation.

Loading comments…